Magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor in a patient with von Willebrand disease: perioperative optimization for patients with coagulopathies. Illustrative case.
Authors: Folz C, Seas A, Chinyengetere F, Beasley C, Harris A, Oyedeji C, Ortel TL, Shah BR, Lad S, Harward SC
Essential tremor (ET) is one of the most common movement disorders worldwide. In medically refractory ET, deep brain stimulation (DBS) of the ventral intermediate nucleus of the thalamus is the current standard of care. However, DBS carries an inherent 2% to 3% risk of hemorrhage, a risk that can be much higher in patients with concomitant coagulopathy. Magnetic resonance imaging-guided focused ultrasound (MRgFUS) thalamotomy is a surgical alternative that is highly effective in treating ET, with no reports of intracranial hemorrhage to date. This is the first documented case of successful MRgFUS thalamotomy in a patient with von Willebrand disease (VWD). A 60-year-old left-handed male had medically refractory ET, VWD type 2B, and a family history of clinically significant hemorrhage after DBS. He underwent right-sided MRgFUS thalamotomy and received a perioperative course of VONVENDI (recombinant von Willebrand factor) to ensure appropriate hemostasis. Postprocedure imaging confirmed a focal lesion in the right thalamus without evidence of hemorrhage. The patient reported 90% improvement of his left-hand tremor and significant improvement in his quality of life without obvious side effects. MRgFUS thalamotomy with peri- and postoperative hematological management is a promising alternative to DBS for patients with underlying coagulopathies.
Introduction
Purpose
Other
Study Objective
To report the safety and effectiveness of MRgFUS thalamotomy with perioperative recombinant von Willebrand factor in a patient with von Willebrand disease and medically refractory essential tremor as an alternative to deep brain stimulation.
Animal model / Human subject
Homo sapiens, not applicable, 60 years, male
Disease model
Essential tremor (medically refractory), with comorbid von Willebrand disease (type 2B)
MRI or image guidance method
Magnetic resonance imaging–guided focused ultrasound (MRgFUS)
Targeted brain region(s)
Thalamus
Target coordinates
Target 1: AP 6.0 mm, ML 12.5 mm, DV 1.5 mm. Target 2: AP 6.4 mm, ML 14.0 mm, DV 3.0 mm
Cargo name and characteristics
Not specified in the provided paper text.
Route of administration
Not applicable (MR-guided focused ultrasound thalamotomy; no drug or cargo delivery reported)
Outcomes and Safety
Summary of Outcomes
MRgFUS thalamotomy with peri- and postoperative recombinant von Willebrand factor produced a 90% reduction in the patient’s left-hand essential tremor and improved quality of life without intracranial hemorrhage.
Duration of biological effect
not reported
Safety-related matter
No intracranial hemmorrhage occurred, only transient dysarthria, gait imbalance, tongue tip numbness, and minor frame pin oozing were reported. Symptoms resolved in 3 days
Brain Region
Ultrasound Parameters
Ultrasound instrument
Magnetic resonance imaging–guided focused ultrasound (MRgFUS) thalamotomy (no specific system model or manufacturer reported; transducer aperture/diameter not reported)
FUS Frequency
Not reported in the provided text
FUS Intensity
Not reported
FUS Pressure
Not reported
FUS Mode
continuous
Pulse duration
not reported
Duration of a single FUS session
Not reported in the provided text.
Focal Characteristics
Not reported
Treatment frequency
single
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search